WARC, 27 February 2014
NEW YORK: Pfizer has moved to tackle the issue of
counterfeiting – and the resulting threat to one of its leading brands – by
rolling out an online home delivery service.
Speaking about Viagra, the erectile dysfunction drug, Lauren
Ljubicich, director/marketing at Pfizer, told delegates at the ePharma Summit –
an event organised by the Institute for International Research and held in New
York this month – that imitations were a big concern.
By way of an indication as to the scale of the problem,
Viagra is Pfizer's most-counterfeited drug, and a significant portion of the 24
million online searches for the product each year were routed to illegitimate
sites.
Distinguishing between the websites selling the real thing
and fakes, Ljubicich continued, is often challenging. (For more, including
details of the consumer insights supporting Pfizer's strategy, read Warc's
exclusive article: How Viagra used ecommerce to take on the counterfeiters.)
"There's not a huge difference between the two,"
she asserted – so that even those consumers who were aware of the risks were
not immune.
Further adding to the confusion, unapproved digital
merchants regularly provided links to "generic" and "real"
Viagra – with Pfizer's analysis showing 80% of goods sold under the second of
these labels were counterfeit.
Even when the fake pills are delivered, separating
reproductions from the genuine article was not easy. In combination, these
factors led to many men with legitimate prescriptions ending up with inadequate
copies.
And the consequences of this situation were undesirable for
a variety of reasons. "It doesn't just hurt us bottom line financially; it
impacts our brand," Ljubicich said.
"It wasn't just a business opportunity; it was also
really our responsibility to figure out this counterfeit situation. We built
the category. We put Viagra out there."
Indeed, the decision to launch an official home delivery
website rested on more than a desire to safeguard the Viagra name, as research
into customer attitudes and behaviours on the web showed it could offer real
benefits to prescription holders beyond guaranteeing the veracity of the
product.
Data sourced from Warc
No comments:
Post a Comment